Interstitial Lung Disease Following Single-Agent Nanoparticle Albumin-Bound Paclitaxel Treatment in Patients with Advanced Non-Small Cell Lung Cancer

Interstitial lung disease (ILD) is a serious and potentially fatal adverse event in lung cancer therapy. Nanoparticle albumin-bound paclitaxel (nab-PTX) is a novel, solvent-free formulation of paclitaxel (PTX). Although the incidence of nab-PTX-induced ILD is not clear, it is generally considered th...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Case Rep Oncol
Hlavní autoři: Nakatani, Yuki, Nakaya, Aya, Kurata, Takayasu, Yokoi, Takashi, Takeyasu, Yuki, Niki, Maiko, Kibata, Kayoko, Satsutani, Naoko, Ogata, Makoto, Miyara, Takayuki, Nomura, Shosaku
Médium: Artigo
Jazyk:Inglês
Vydáno: S. Karger AG 2017
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5582424/
https://ncbi.nlm.nih.gov/pubmed/28878650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000479148
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky